Nanomedicine drug hits brain tumor

Employing new drug-engineering technology, a research team has created a 'nanobioconjugate' drug that may be given by intravenous injection and carried in the blood to target a brain tumor. It is engineered to specifically permeate the tumor cell wall, entering endosomes, mobile compartments within cells.

Related Posts

Comments are closed.